Cite
HARVARD Citation
Jung, S. et al. (2018). Heterologous prime–boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus. Vaccine. 36 (24), pp. 3468-3476. [Online].